Read + Share
Liefaard MC, van der Voort A, van Ramshorst MS, Sanders J, et al. BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in
HER2-positive breast cancer. Breast Cancer Res 2023;25:71.
PMID: 37337299
|
 |
|
Liefaard MC, van der Voort A, van Ramshorst MS, Sanders J, et al. BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in
HER2-positive breast cancer. Breast Cancer Res 2023;25:71.
PMID: 37337299
|
|
|
|